Chronic catestatin treatment reduces atrial fibrillation susceptibility via improving calcium handling in post-infarction heart failure rats

M Yan, T Liu, P Zhong, F Xiong, B Cui, J Wu, G Wu - Peptides, 2023 - Elsevier
… phosphorylated-Ca 2+ /calmodulin-dependent protein kinase II in … (RyR2) -mediated
sarcoplasmic reticulum (SR) Ca 2+ leakage [… of Ca 2+ handling by targeted SERCA2a gene

[HTML][HTML] ER stress and calcium-dependent arrhythmias

S Hamilton, D Terentyev - Frontiers in Physiology, 2022 - frontiersin.org
sarcoplasmic reticulum (SR) plays the key role in cardiac … Importantly, inhibition of ERO1α
was able to restore intra-SR … , as off-target effects in organs other than the heart can be avoided…

Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies

G Angelini, G Mura, G Messina - Experimental Cell Research, 2022 - Elsevier
… associated with AAV and drug delivery, the limitation of free … , causes reduced sarcoplasmic
reticulum (SR) Ca 2+ release, … the advantage to target both skeletal and cardiac muscles, …

Optical mapping of sarcoplasmic reticulum Ca2+ and transmembrane potential in the intact heart: insights into Ca2+− mediated arrhythmias

L Wang, CM Ripplinger - Cardiac Mapping, 2019 - books.google.com
Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability
in the failing heart. Circulation 2012; 126 (17): 2095–104. Stefenelli T, Wikman‐Coffelt J, …

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure …

RA de Boer, S Heymans, J Backs… - … of heart failure, 2022 - Wiley Online Library
… ) is a protein in the sarcoplasmic reticulum membrane that … to repair the genetic defect (eg
antisense and gene therapy), … expression of a stable dystrophin gene. Functional assessment, …

[HTML][HTML] Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy

TA Meyers, DW Townsend - International journal of molecular sciences, 2019 - mdpi.com
… may benefit from combining gene-targeted therapies with small … may also come from the
sarcoplasmic reticulum (SR) in … viral gene delivery, the pursuit of a DMD gene therapy faces …

Ion channel trafficking implications in heart failure

JB Reisqs, YS Qu, M Boutjdir - Frontiers in Cardiovascular Medicine, 2024 - frontiersin.org
… NCX blocker restores the sarcoplasmic reticulum (SR) Ca2+ … largest gene transfer clinical
studies (CUPID2), targeting the … channels are packaged in coatomer protein II (COPII) vesicles. …

[HTML][HTML] Modified mRNA as a Therapeutic Tool for the Heart

K Kaur, L Zangi - Cardiovascular Drugs and Therapy, 2020 - Springer
therapy is a promising gene delivery platform for cardiac … of gene delivery assisted by viral
vectors, the target gene must … function by overexpressing a target molecule [13, 29], (ii) loss of …

Impaired SERCA2a phosphorylation causes diabetic cardiomyopathy through impinging on cardiac contractility and precursor protein processing

C Quan, S Zhu, R Wang, J Chen, Q Chen, M Li… - Life …, 2022 - academic.oup.com
sarcoplasmic reticulum in the cardiomyocytes and decreases … that SERCA2a is not only a
target of the insulin−PKB … ], which can be enhanced through gene transfer of SUMO-1 or small …

[HTML][HTML] MicroRNA-20b promotes cardiac hypertrophy by the inhibition of mitofusin 2-mediated inter-organelle Ca2+ cross-talk

Y Qiu, R Cheng, C Liang, Y Yao, W Zhang… - Molecular Therapy …, 2020 - cell.com
… tissues after TAC and a restoration by administration of rAAV9-… Ca 2+ and the decrease in
mitochondrial Ca 2+ in Ang II-… miRNA in the heart by targeting Mfn2. Overexpression of miR-…